Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Kubota Pharmaceutical Holdings Co., Ltd. clinical trials
Also known as Acucela.
The registry lists 21 studies whose lead sponsor is Kubota Pharmaceutical Holdings Co., Ltd. or one of 1 company grouped under it. 2 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jul 7, 2026.
Keep track of what changes. Save the Kubota Pharmaceutical Holdings Co., Ltd. studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesRegistry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Kubota Pharmaceutical Holdings Co., Ltd..
- Kubota Vision Inc.21 studies →Subsidiary
Something wrong?
Studies
Recruiting first, then most recently updated. Showing 21 of 21.
- A Controlled Evaluation of Optical Defocus Parameters on Transient Changes in Axial Length Using Kubota GlassNot yet recruitingNCT07686289Not applicable
Sponsor listed in the registry: Kubota Vision Inc.
- Electronic Spectacles Versus Low Dose Atropine in Young MyopesRecruitingNCT06034379Not applicable
Sponsor listed in the registry: Kubota Vision Inc.
- Kubota Glass Parameter Refinement StudyCompletedNCT06085430Not applicable
Sponsor listed in the registry: Kubota Vision Inc.
- Safety and Efficacy of Emixustat in Stargardt DiseaseCompletedNCT03772665Phase 3
Sponsor listed in the registry: Kubota Vision Inc.
- Binocular Peripheral Myopic Defocus Using a Clinical Prototype DeviceStatus unknownNCT05425108Not applicable
Sponsor listed in the registry: Kubota Vision Inc.
- Projected Peripheral Defocus Using a Wearable DeviceCompletedNCT04415684Not applicable
Sponsor listed in the registry: Kubota Vision Inc.
- Effects of Projected Peripheral Defocus on Ocular BiometricsCompletedNCT04388020Not applicable
Sponsor listed in the registry: Kubota Vision Inc.
- Pharmacodynamic Study of Emixustat Hydrochloride in Subjects With Macular Atrophy Secondary to Stargardt DiseaseCompletedNCT03033108Phase 2
Sponsor listed in the registry: Kubota Vision Inc.
- Study to Evaluate Effects of Emixustat Hydrochloride in Subjects With Proliferative Diabetic RetinopathyCompletedNCT02753400Phase 2
Sponsor listed in the registry: Kubota Vision Inc.
- Study Evaluating Retinal Health Monitoring System Thickness ModuleWithdrawnNCT04428242
Sponsor listed in the registry: Kubota Vision Inc.
- Study Evaluating Retinal Health Monitoring System Visual Acuity Module.CompletedNCT04169802
Sponsor listed in the registry: Kubota Vision Inc.
- Evaluation of the Retinal Health Monitoring System Thickness ModuleCompletedNCT04499703
Sponsor listed in the registry: Kubota Vision Inc.
- Safety and Efficacy Assessment Treatment Trials of Emixustat HydrochlorideCompletedNCT01802866Phase 2/3
Sponsor listed in the registry: Kubota Vision Inc.
- Pharmacokinetic and Pharmacodynamic Study of Emixustat in Subjects With Geographic Atrophy Associated With Dry Age-Related Macular DegenerationCompletedNCT02130531Phase 1
Sponsor listed in the registry: Kubota Vision Inc.
- Efficacy and Safety of Rebamipide in Subjects With Dry Eye SyndromeCompletedNCT01632137Phase 3
Sponsor listed in the registry: Kubota Vision Inc.
- Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACU-4429 in Subjects With Geographic AtrophyCompletedNCT01002950Phase 2
Sponsor listed in the registry: Kubota Vision Inc.
- Safety/Efficacy Study: OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular HypertensionCompletedNCT01410188Phase 1/2
Sponsor listed in the registry: Kubota Vision Inc.
- Safety and Tolerability of ACU-4429CompletedNCT00703183Phase 1
Sponsor listed in the registry: Kubota Vision Inc.
- Safety and Efficacy Study of Rebamipide 2% Ophthalmic Suspension in Patients With Dry EyeCompletedNCT01027013Phase 2
Sponsor listed in the registry: Kubota Vision Inc.
- Safety and Efficacy Study of Rebamipide 2% Ophthalmic Suspension in Subjects With Dry Eye - Effects on Central CorneaCompletedNCT01057147Phase 2
Sponsor listed in the registry: Kubota Vision Inc.
- Safety and Tolerability of Repeat Doses of ACU-4429 in Healthy SubjectsCompletedNCT00942240Phase 1
Sponsor listed in the registry: Kubota Vision Inc.